U.S. Markets open in 3 hrs, 48 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 10,433.71 | -17.24 | -0.16% |
| NASDAQ | 2,169.18 | -6.83 | -0.31% |
| S&P 500 | 1,105.65 | -0.59 | -0.05% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| Day Low | 0.96 09:30 AM EST | |
|---|---|---|
| Day High | 1.16 10:26 AM EST |
|
| Range | 0.20 |
| Volume | 8.23 M | |
|---|---|---|
| 30-Day Avg Vol | 1.87 M |
|
| Difference | 338.70% |
| Market Cap | 109.52 M | |
|---|---|---|
| Mkt Cap Chg | 10.10 M |
| Shares Out | 106.33 M | |
|---|---|---|
| % Shrs Traded | 7.74% | |
| 1yr EPS Est | -0.15 |
| 52-Wk Low | 0.01 | |
|---|---|---|
| 52-Wk High | 1.17 |
|
| Range | 1.16 |
| Prev Close | 0.935 11/23/09 | |
|---|---|---|
| Today's Open | 0.96 | |
| Change | 2.67% |
| Dividend (TTM) | 0.00 | |
|---|---|---|
| Div Yield (TTM) | 0.00% | |
| Ex-Div Date | — | |
| Div Date | — |
|
| Short Interest | 8.9 M |
| Revenue (LFY) | 15.12 M | |
|---|---|---|
| Earnings (LFY) | -26.06 M | |
| Earnings (MRQ) | -3.56 M | |
| Next Earn Est | -0.03 | |
| Next Earnings | 11/12/2010 |
|
| EPS (TTM) | -0.22 | |
| 1yr EPS Growth | 31.82% |
| P/E Ratio (TTM) | — | |
|---|---|---|
| P/E Ratio (Fwd) | -6.00 | |
| PEG Ratio | — | |
| Return on Equity | -159.63 | |
| Beta | 2.18 |
| Sector | Healthcare | |
|---|---|---|
| Industry | Drugs |
above for more info
GenVec is all over the medical map. The clinical-stage biopharmaceutical firm develops gene-based drugs and vaccines for everything from cancer to HIV. Its lead candidate, TNFerade, may boost the effectiveness ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| Next Quarter | -0.03 N/A | — — |
—
—
|
| Last Quarter | -0.04 9/30/09 | -0.04 9/30/09 |
0.00
Met
|
| 2 Quarters Ago | -0.07 6/30/09 | -0.05 6/30/09 |
0.02
Beat
|
| Quarterly - 09/30/2009 | Annual - 2008 | |
|---|---|---|
| Total Revenue | 2.93 M | 15.12 M |
| Gross Profit | 2.92 M | 14.18 M |
| Operating Income | -3.57 M | -26.68 M |
| Net Income | -3.56 M | -26.06 M |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts